NOVN.SW

Novartis AG EBS · NOVN.SW

$125.34 -0.20 (-0.16%)

Neutral · +0.55σ

+ Compare Open in Sniper

Mkt cap $238.2B

P/E 22.2

Day $124.12 – $126.96

52wk $108.24 – $131.00

Avg vol 2.8M

Beta —

Div yld 2.95%

Next earnings 2026-07-21

Quick read

At a glance

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

NOVN.SW last traded at $125.34, down 0.2% on the day; that's in the upper part of its 52-week range ($108.24–$131.00). Right now it's trading close to its recent average, with no strong stretch in either direction.

The next scheduled earnings report (2026-07-21) is the biggest known catalyst on the calendar, and day to day, watch whether it holds above or slips below its recent average.

A quick snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

Price is stretched slightly above its normal range — a light stretch — early days, worth watching.

Long —

Setup score 12 / 100

Price is sitting close to its normal range — no real dip to buy yet.

· Aligned with weak uptrend

Technical read: above KC1 lower, +0.53 ATR from EMA21 · no notable pattern

What it means: Price is sitting close to its normal range — no real dip to buy yet. The trigger bar shows no standout candle signal yet.

Score split: chart signals 12 / 80 · news & fundamentals checks 0 / 20 — chart signals carry most of the grade.

How this grade was earned

total 12 pts

Cycle position 6

Market fit 6

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short —

Setup score 23 / 100

Price is stretched slightly above its normal range — a light stretch — early days, worth watching.

· KC1 upper stretch — light pop
· RSI hook from overbought (55)

Technical read: KC1 upper, +0.53 ATR from EMA21 · no notable pattern

What it means: Price is stretched slightly above its normal range — a light stretch — early days, worth watching. The trigger bar shows no standout candle signal yet.

Score split: chart signals 23 / 80 · news & fundamentals checks 0 / 20 — chart signals carry most of the grade.

How this grade was earned

total 23 pts

Cycle position 14

Momentum 6

Market fit 3

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Key statistics

All statistics →

NOVN.SW is a $238.2 billion company, priced at 22× last year's earnings.

Market cap $238.2B

P/E ttm 22.2

Beta —

52w range $108.24 – $131.00

Avg volume 2.8M

Dividend yield 2.95%

Sector Healthcare

Next earnings 2026-07-21

52-week range · today's price

$108.24$131.00

More on NOVN.SW

Earnings

See more →

Last reported: 2026-07-20
EPS (act / est): 2.41 / 2.14
Surprise: +12.7%
Next report: 2026-10-27

About

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, a…